miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB

BACKGROUND: Cisplatin (CDDP) is extensively used for esophageal adenocarcinoma (EAC) chemotherapy, while cisplatin resistance is getting worse. microRNA-181a-5p (miR-181a-5p) has been reported to play an important role in various human cancers. However, the effect and underlying mechanism of miR-181...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Song, Wang, Peng, Wang, Songhua, Cong, Aihua, Zhang, Qi, Shen, Wenhao, Li, Xiangyi, Zhang, Wei, Han, Gaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323973/
https://www.ncbi.nlm.nih.gov/pubmed/32612385
http://dx.doi.org/10.2147/CMAR.S251264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323973/
https://www.ncbi.nlm.nih.gov/pubmed/32612385
http://dx.doi.org/10.2147/CMAR.S251264

Ejemplares similares